top of page
Doctor Using Digital Tablet_edited.jpg


Curespec is ushering in a new era of hope for chronic kidney disease (CKD) and hypertensive patients with Nephrospec™, our cutting-edge technology.

We stand as pioneers, offering a life-extending treatment that revitalizes kidneys, delays the need for dialysis, and lowers blood pressure, all while making significant cost savings for healthcare systems.

Nephrospec™ is a safe, non-invasive low intensity electro-Hydraulic Acoustic Therapy (eHAT) device for the treatment of CKD and hypertension. 

Our patented technology promotes new blood vessel formation and restores damaged tissue function while saving up to 80% of the costs associated with dialysis.


Nephrospec™ by Curespec:

A complementary solution to optimize medical care for CKD and     hypertension

Improvement of kidney function within a few weeks 

Delayed onset of outpatient treatment for dialysis

Nephrospec- curespec logo_edited_edited_edited.jpg


Pre treatment

ARAS Kidney

Post Nephrospec™ treatment

Curespec uses electro-Hydro Acoustic Therapy to produce a neovascularization effect on the kidneys


Low–Energy Shockwave Therapy Improves Ischemic Kidney Microcirculation

Zhang X, Krier JD, Carrascal CA, et al.

J Am Soc Nephrol. 2016; 27(12):3715-3724. 

Low-Energy Shockwave Treatment Promotes Endothelial Progenitor Cell Homing to the Stenotic Pig Kidney

Zhao Y, Santelli A, Zhu XY, et al.

Cell Transplant. 2020; 29.

Magnetic resonance elastography can monitor changes in medullary  stiffness in response to treatment in the swine ischemic kidney

Zhang X, Zhu X, Ferguson CM, et al.

Magn Reson Mater Physics, Biol Med. 2018; 31(3):375-382.

Adjunctive mesenchymal stem / stromal cells augment microvascular function in poststenotic kidneys treated with low-energy shockwave therapy

Chen X-J, Zhang X, Jiang K, et al

J Cell Physiol. 2020; 235(12):9806-9818. 

It Comes As a Shock

Kidney Repair Using Shockwave Therapy

Klomjit N, Lerman A, Lerman LO.

Hypertension. Published online 2020:1696-1703. 

Innovation in Cardiovascular Interventions Meeting:
First results using a new renal restoration approach to treat hypertension and preserve renal function in CKD patients -
Presented by Prof. Talya Wolak

Our Team

Our Team

Avner Spector_edited.jpg

Avner Spector

Founder, Active Chairman

Mr. Spector has over 30 years experience in the international Medtech industry, having held top R&D management positions in medical instrument companies in Israel and the US. 

  • Grey LinkedIn Icon
rotem k_edited.jpg

Rotem Kaynan


Mr. Kaynan is a Biomedical Engineer. More than 20 years of experience in Medical Devices, leading teams of clinical applications, sales & product management.

  • Grey LinkedIn Icon

Sandra Morgan

Executive Advisor

Ms.  Morgan has over  32 years in healthcare with Fortune 100 companies including HCA Healthcare and Pfizer. In the past she was an executive at HCA Healthcare responsible for business growth through physicians and service lines. In her last role at Pfizer, Sandra led the US managed care team responsible for achieving formulary status for Pfizer’s portfolio.

  • Grey LinkedIn Icon

Alex Slutzker

VP Clinical, Cofounder

Dr. Slutzker (Ph.D) has 15 years of experience in the clinical diagnostics and medical device fields. He holds a doctorate in the fields of Molecular biology, biochemistry and microbiology .

  • Grey LinkedIn Icon

Lilach O. Lerman, MD, PhD

The Arthur M. and Gladys D. Gray Professor in Honor of Dr. Howard A. Andersen Professor of Medicine and Physiology Director, Reno- Vascular Research Laboratory Division of Nephrology and Hypertension Mayo Clinic


Amir Lerman, M.D.

Barbara Woodward Lips Professor 

Associate Chair, Cardiovascular  Medicine Director - Cardiovascular Research Center Consultant, Department of Cardiovascular Medicine Mayo Clinic


Hagay Spector

R&D Director

Mr. Spector is an Electronics Engineer. His major expertise is Product Development in all of its layers with wide knowledge in Shockwave systems and X-ray Vision. 

  • Grey LinkedIn Icon
yael shpilman.jpg

Yael Spielmann

RA Manager

Ms. Spielmann has over 20 years of experience in the medical device industry, serving as a Regulatory Affairs expert, developing regulatory strategies and compiling submissions to regulatory bodies worldwide.

  • Grey LinkedIn Icon

Advisory Board

Contact Us

Contact Us

Thanks for submitting!

  • Instagram
  • Facebook
  • LinkedIn
bottom of page